Page 17 - Query Get News Today

DENVER — Patients with diabetic macular edema were able to maintain visual acuity improvements long term despite receiving fewer anti-VEGF injections as treatment progressed, according to a study.

Adolescent boys exposed to higher levels of two types of endocrine-disrupting chemicals may have lower areal bone mineral density, according to study data published in The Journal of Clinical Endocrinology & Metabolism. “Per- and polyfluoroalkyl substances (PFAS) and phthalates are detectable in the blood of almost all individuals in the U.S., but few studies have looked at how these

Corneal hysteresis was a significant risk factor for glaucomatous central and peripheral visual field progression, according to a study published in the American Journal of Ophthalmology.

Lung function in extremely preterm infants fell significantly below trajectories of term-born children in early adult life, researchers reported in BMJ Thorax.“This is the first longitudinal study to describe lung function trajectories from childhood and well into adulthood for population-based cohorts of extremely preterm-born survivors,” Tonje Bårdsen, MD, from the department of

Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are de-coppered and tolerant to penicillamine, according to a company press release.

Strive Health is expanding its relationship with Nephrology Associates of Northern Illinois and Indiana to help manage up to 20,000 patients with kidney disease, according to a company press release.

Supernus Pharmaceuticals announced FDA approval of viloxazine extended-release capsules to treat ADHD in patients aged 18 years and older.The FDA has now given its consent to viloxazine (Qelbree, Supernus), a once-per-day oral nonstimulant for the treatment of ADHD, starting with children aged 6 years, as well as adolescents and adults, a company press release stated.

A novel catheter-based cardioneural ablation procedure reduced symptoms of vasovagal syncope by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.Early published reports of cardioneural ablation have shown promise for the relief of autonomically mediated bradycardia; however, cases are typically performed on a

Among patients hospitalized with COVID-19, dapagliflozin was well tolerated and did not increase risk of AKI in patients, according to data published in the Clinical Journal of the American Society of Nephrology.Further, dapagliflozin was well tolerated among patients with an eGFR below 60 mL/minute per 1.73² and among those with an eGFR above 60 mL/minute per 1.73².

An analysis of single-center data showed same-day discharge after atrial fibrillation ablation increased from 2020 to 2021, with reduction in total time spent in-hospital and no change in readmission rates for adverse events. Same-day discharge after AF ablation may be associated with improved patient satisfaction and reduced hospital resource utilization, Bruce A. Koplan, MD, MPH, FHRS, a